MAPT and Alzheimer disease: To date, the diagnosis of prodromal-to-AD MCI can be reached with high sensitivity and specificity by combining different tests (e.g., hippocampal volumetric MRI, PET integrated with beta-amyloid and tau radioligands, cerebrospinal fluid beta, and tau metabolites dosage).